Michael Shannon Anderson

Michael Shannon Anderson

Directeur Général chez
New American Therapeutics, Inc.
77 ans
Health Technology

Profil

Michael Shannon Anderson is the founder of Avadel Legacy Pharmaceuticals LLC, which was founded in 2010.
He held the title of President & Chief Executive Officer at Avadel Legacy Pharmaceuticals LLC.
Currently, Mr. Anderson is the Chief Executive Officer at New American Therapeutics, Inc. In the past, he held the position of Chief Executive Officer at Flamel Technologies SA in 2012, Chief Executive Officer at Lumara Health Services Ltd. from 2000 to 2006, President & Chief Executive Officer at Ethex Corp.
in 2010, and Chief Executive Officer & Director at Avadel Pharmaceuticals Plc from 2012 to 2019.
Additionally, he worked as Vice President-Industry Presence & Development at AMAG Pharma USA, Inc.

Postes actifs de Michael Shannon Anderson

SociétésPosteDébut
Directeur Général -

Anciens postes connus de Michael Shannon Anderson

SociétésPosteFin
AVADEL PHARMACEUTICALS PLC Directeur Général 03/01/2019
Ethex Corp.
President 30/04/2010
President 01/02/2006
Directeur Général -
Directeur Général -
Voir l'expérience en détail de Michael Shannon Anderson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

21

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Ethex Corp.

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Shannon Anderson
🔇